Biomarker Research Study for PF-03084014 in cHEmoresistant Triple-negative Breast cAncer
Status: WITHDRAWN
Study type: INTERVENTIONAL
Conditions: Breast Cancer
Interventions: DRUG: PF-03084014|PROCEDURE: Breast cancer surgery
Sponsor: Jules Bordet Institute